| 中文摘要 |
根據衛生署九十八年統計十大死亡原因，慢性肝病與肝硬化高居我國十大死因之第七位，每年大約有五千人死亡，可謂之為國病，也因此付出巨大的社會成本。無論中西醫學者針對慢性肝病患者進一步轉變成肝纖維化或肝硬化，在臨床或實驗室研究中，莫不思考相關因應對策，以求其突破瓶頸。本文藉以古籍論述、近代古今中醫學及現階段中醫藥研究針對肝纖維化之看法做一比較，探討未來中醫在臨床上對肝纖維化的治療策略。According to statistical information gathered by the Department of Health, chronic liver disease and liver cirrhosis are currently ranked at number 7 out of the top 10 leading causes of death in 2009. In the ROC, on average 5,000 citizens die each year from liver disease, making it a national epidemic. Regardless of race or location, some patients who have chronic liver disease will eventually get liver fibrosis or liver cirrhosis. Both Chinese or Western physicians are actively studying clinical and laboratory research and trying hard to find a breakthrough, which has yet to be found that can offer a solution to face this growing problem. This article is comparing and discussing the Chinese theory of liver fibrosis from antiquity to the previous century, as well as focusing on Chinese medicine’s research in the current day. It is also an analysis of the strategy of Chinese medicine dealing with anti-liver fibrosis concepts to find a cure in the future. |
本站僅提供期刊文獻檢索。
